Literature DB >> 25917555

Primary disease recurrence—effects on paediatric renal transplantation outcomes.

Justine Bacchetta1, Pierre Cochat1.   

Abstract

Primary disease recurrence after renal transplantation is mainly diagnosed by examination of biopsy samples, but can also be associated with clinical symptoms. In some patients, recurrence can lead to graft loss (7-8% of all graft losses). Primary disease recurrence is generally associated with a high risk of graft loss in patients with focal segmental glomerulosclerosis, membranous proliferative glomerulonephritis, primary hyperoxaluria or atypical haemolytic uraemic syndrome. By contrast, disease recurrence is associated with a limited risk of graft loss in patients with IgA nephropathy, renal involvement associated with Henoch-Schönlein purpura, antineutrophil cytoplasmic antibody-associated glomerulonephritis or lupus nephritis. The presence of systemic diseases that affect the kidneys, such as sickle cell anaemia and diabetes mellitus, also increases the risk of delayed graft loss. This Review provides an overview of the epidemiology, pathophysiology and management of primary disease recurrence in paediatric renal graft recipients, and describes the overall effect on graft survival of each of the primary diseases listed above. With appropriate management, few paediatric patients should be excluded from renal transplantation programmes because of an increased risk of recurrence.

Entities:  

Mesh:

Year:  2015        PMID: 25917555     DOI: 10.1038/nrneph.2015.54

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  130 in total

1.  IgA nephropathy recurs early in the graft when assessed by protocol biopsy.

Authors:  Fernanda Ortiz; Rosana Gelpi; Petri Koskinen; Anna Manonelles; Anne Räisänen-Sokolowski; Marta Carrera; Eero Honkanen; Josep M Grinyó; Josep M Cruzado
Journal:  Nephrol Dial Transplant       Date:  2011-12-13       Impact factor: 5.992

2.  Predictors of outcome in Henoch-Schönlein nephritis in children and adults.

Authors:  Rosanna Coppo; Simeone Andrulli; Alessandro Amore; Bruno Gianoglio; Giovanni Conti; Licia Peruzzi; Francesco Locatelli; Leonardo Cagnoli
Journal:  Am J Kidney Dis       Date:  2006-06       Impact factor: 8.860

3.  Rituximab in post-transplant pediatric recurrent focal segmental glomerulosclerosis.

Authors:  Juhi Kumar; Ibrahim F Shatat; Amy L Skversky; Robert P Woroniecki; Marcela Del Rio; Eduardo M Perelstein; Valerie L Johnson; Shefali Mahesh
Journal:  Pediatr Nephrol       Date:  2012-10-04       Impact factor: 3.714

4.  Antiphospholipid antibody syndrome in renal transplantation: occurrence of clinical events in 96 consecutive patients with systemic lupus erythematosus.

Authors:  J H Stone; W J Amend; L A Criswell
Journal:  Am J Kidney Dis       Date:  1999-12       Impact factor: 8.860

Review 5.  Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children.

Authors:  Chantal Loirat; Jean-Pierre Girma; Céline Desconclois; Paul Coppo; Agnès Veyradier
Journal:  Pediatr Nephrol       Date:  2008-06-24       Impact factor: 3.714

6.  Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.

Authors:  Anne-Laure Sellier-Leclerc; Veronique Fremeaux-Bacchi; Marie-Agnès Dragon-Durey; Marie-Alice Macher; Patrick Niaudet; Geneviève Guest; Bernard Boudailliez; François Bouissou; Georges Deschenes; Sophie Gie; Michel Tsimaratos; Michel Fischbach; Denis Morin; Hubert Nivet; Corinne Alberti; Chantal Loirat
Journal:  J Am Soc Nephrol       Date:  2007-06-28       Impact factor: 10.121

7.  Hemolytic uremic syndrome recurrence after renal transplantation.

Authors:  Chantal Loirat; Véronique Fremeaux-Bacchi
Journal:  Pediatr Transplant       Date:  2008-05-10

8.  The podocin mutation R229Q and early recurrence (within the first year) of glomerular disease after renal transplantation.

Authors:  Hesham Mohey; Lise Thibaudin; Blandine Laurent; Francois Berthoux
Journal:  Ann Transplant       Date:  2013-08-28       Impact factor: 1.530

9.  Impact of graft loss among kidney diseases with a high risk of post-transplant recurrence in the paediatric population.

Authors:  Karlijn J Van Stralen; Enrico Verrina; Mirco Belingheri; Jan Dudley; Jirí Dusek; Ryszard Grenda; Marie-Alice Macher; Zvonimir Puretic; Jacek Rubic; Sarunas Rudaitis; Christoph Rudin; Franz Schaefer; Kitty J Jager
Journal:  Nephrol Dial Transplant       Date:  2013-01-08       Impact factor: 5.992

10.  Long-term activity index after renal failure in a cohort of 32 patients with lupus nephritis.

Authors:  C González-Pulido; S Croca; E Abrol; D A Isenberg
Journal:  Clin Exp Rheumatol       Date:  2014-04-07       Impact factor: 4.473

View more
  13 in total

1.  LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients.

Authors:  Lokesh Shah; David K Hooper; Daryl Okamura; Dean Wallace; Divya Moodalbail; Caroline Gluck; Ania Koziell; Joshua J Zaritsky
Journal:  Pediatr Nephrol       Date:  2019-06-27       Impact factor: 3.714

2.  Whole-Exome Sequencing Enables a Precision Medicine Approach for Kidney Transplant Recipients.

Authors:  Nina Mann; Daniela A Braun; Kassaundra Amann; Weizhen Tan; Shirlee Shril; Dervla M Connaughton; Makiko Nakayama; Ronen Schneider; Thomas M Kitzler; Amelie T van der Ven; Jing Chen; Hadas Ityel; Asaf Vivante; Amar J Majmundar; Ankana Daga; Jillian K Warejko; Svjetlana Lovric; Shazia Ashraf; Tilman Jobst-Schwan; Eugen Widmeier; Hannah Hugo; Shrikant M Mane; Leslie Spaneas; Michael J G Somers; Michael A Ferguson; Avram Z Traum; Deborah R Stein; Michelle A Baum; Ghaleb H Daouk; Richard P Lifton; Shannon Manzi; Khashayar Vakili; Heung Bae Kim; Nancy M Rodig; Friedhelm Hildebrandt
Journal:  J Am Soc Nephrol       Date:  2019-01-17       Impact factor: 10.121

3.  Hemolytic uremic syndrome in a developing country: Consensus guidelines.

Authors:  Arvind Bagga; Priyanka Khandelwal; Kirtisudha Mishra; Ranjeet Thergaonkar; Anil Vasudevan; Jyoti Sharma; Saroj Kumar Patnaik; Aditi Sinha; Sidharth Sethi; Pankaj Hari; Marie-Agnes Dragon-Durey
Journal:  Pediatr Nephrol       Date:  2019-04-15       Impact factor: 3.714

4.  C3 glomerulopathy and eculizumab: a report on four paediatric cases.

Authors:  Célia Lebreton; Justine Bacchetta; Frédérique Dijoud; Lucie Bessenay; Véronique Fremeaux-Bacchi; Anne Laure Sellier-Leclerc
Journal:  Pediatr Nephrol       Date:  2017-02-24       Impact factor: 3.714

5.  Precise clinicopathologic findings for application of genetic testing in pediatric kidney transplant recipients with focal segmental glomerulosclerosis/steroid-resistant nephrotic syndrome.

Authors:  Kenichiro Miura; Naoto Kaneko; Taeko Hashimoto; Kiyonobu Ishizuka; Yoko Shirai; Masataka Hisano; Hiroko Chikamoto; Yuko Akioka; Shoichiro Kanda; Yutaka Harita; Toshiyuki Yamamoto; Motoshi Hattori
Journal:  Pediatr Nephrol       Date:  2022-06-02       Impact factor: 3.714

Review 6.  Management and outcomes in children with lupus nephritis in the developing countries.

Authors:  Priyanka Khandelwal; Srinivasavaradan Govindarajan; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2022-10-18       Impact factor: 3.651

7.  Pediatric combined liver-kidney transplantation: a single-center experience of 18 cases.

Authors:  Rémi Duclaux-Loras; Justine Bacchetta; Julien Berthiller; Christine Rivet; Delphine Demède; Etienne Javouhey; Rémi Dubois; Frédérique Dijoud; Alain Lachaux; Lionel Badet; Olivier Boillot; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2016-04-08       Impact factor: 3.714

8.  Outcome of kidney transplantation in pediatric patients with ANCA-associated glomerulonephritis: a single-center experience.

Authors:  Damien Noone; Rae S M Yeung; Diane Hebert
Journal:  Pediatr Nephrol       Date:  2017-08-01       Impact factor: 3.651

Review 9.  Recurrence and Treatment after Renal Transplantation in Children with FSGS.

Authors:  Hee Gyung Kang; Il-Soo Ha; Hae Il Cheong
Journal:  Biomed Res Int       Date:  2016-04-24       Impact factor: 3.411

10.  Rituximab is not a "magic drug" in post-transplant recurrence of nephrotic syndrome.

Authors:  Ryszard Grenda; Wioletta Jarmużek; Jacek Rubik; Barbara Piątosa; Sylwester Prokurat
Journal:  Eur J Pediatr       Date:  2016-06-30       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.